Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 1

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
545,735 shares issued of which 18,517,376 shares are outstanding at March 31, 2025; and 6,216,398 shares issued of which 6,190,072 shares outstanding at June 30, 2024 
     7,463  
     6,229 
  
    Additional paid in capital 
     370,465,616  
     349,732,674 
  
    Accumulated deficit 
     (348,655,105) 
     (334,232,661)
  
    Treasury stock 
     (29) 
     (27)
  
    Total stockholders' equity 
     21,817,945  
     15,506,215 

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 
    $24,660,215  
    $25,208,345 

See accompanying notes to unaudited condensed financial
statements

 4 

Table of Contents 

BioVie Inc.

Condensed Statements of Operations and Comprehensive
Loss

(Unaudited)

    Three Months Ended  
    Three Months Ended  
    Nine Months Ended  
    Nine Months Ended 

    March 31, 2025  
    March 31, 2024  
    March 31, 2025  
    March 31, 2024 

    OPERATING EXPENSES: 

    Amortization of intangible assets 
    $57,344  
    $57,344  
    $172,033  
    $172,033 
  
    Research and development expenses 
     1,344,991  
     5,700,447  
     8,042,379  
     21,046,369 
  
    Selling, general and administrative expenses 
     1,585,869  
     1,974,264  
     6,188,703  
     6,170,883 
  
    TOTAL OPERATING EXPENSES 
     2,988,204  
     7,732,055  
     14,403,115  
     27,389,285 

    LOSS FROM OPERATIONS 
     (2,988,204) 
     (7,732,055) 
     (14,403,115) 
     (27,389